Page last updated: 2024-11-06

eterilate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

eterilate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID44258
CHEMBL ID2104226
CHEBI ID135509
SCHEMBL ID24764
MeSH IDM0067975

Synonyms (36)

Synonym
etersalatum [latin]
2-(4-acetamidophenoxy)ethyl 2-acetoxybenzoate
benzoic acid, 2-(acetyloxy)-, 2-(4-(acetylamino)phenoxy)ethyl ester
2-(acetyloxy)benzoic acid 2-(4-(acetylamino)phenoxy)ethyl ester
etherylate
etersalato [spanish]
einecs 263-780-3
etersalate
eterilate
brn 2399685
daital
salicylic acid acetate, ester with beta-hydroxy-p-acetophenetidide
eterilato [spanish]
etersalate [inn]
eterylate
CHEBI:135509
2-(4-acetamidophenoxy)ethyl 2-acetyloxybenzoate
etersalato
653gn04t2g ,
eterilato
etersalatum
62992-61-4
unii-653gn04t2g
CHEMBL2104226
etersalate [mart.]
salicylic acid acetate, ester with .beta.-hydroxy-p-acetophenetidide
etersalate [mi]
eterylate [who-dd]
SCHEMBL24764
etersalat
DTXSID60212203
HY-101606
CS-6647
eterylate; etherylate
Q27263820
AKOS040741713

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Oral doses of 14C-eterylate were well absorbed by rat and man and excreted mainly in the urine (94% dose by rat in three days and 91% by man in five days)."( The metabolism of the anti-inflammatory drug eterylate in rat, dog and man.
Biggs, SR; Chasseaud, LF; Darragh, A; Hawkins, DR; John, BA; Johnstone, I; Lambe, RF; Priego, JG; Wood, SG, 1983
)
0.27

Dosage Studied

ExcerptRelevanceReference
" Etersalate inhibited at the lower dosage platelet function and decreased TXA2 levels, but PGI2 generation from rat aortic rings was stimulated when incubated with plasma from etersalate-treated donors."( Effect of etersalate on human platelet responsiveness. A study in healthy volunteers.
Armijo, M; Ortega, MP; Priego, JG; Sunkel, C, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
salicylatesAny salt or ester arising from reaction of the carboxy group of salicylic acid, or any ester resulting from the condensation of the phenolic hydroxy group of salicylic acid with an organic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]